Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib for malignant peripheral nerve sheath tumors
2005-004774-24Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in malignant peripheral nerve sheath tumor (MPNST), sponsored by Novartis. Primary endpoint: Tumor response. Started Jan 2006; status: terminated.
02
Drugs
03
Conditions
malignant peripheral nerve sheath tumor (MPNST)
Beyond the preview
Go deeper on 2005-004774-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004774-24.